AUTOLUS THERAPEUTICS P
3.2700
27-November-24 16:45:00
15 minutes delayed
Stocks
+0.1750
+5.65%
Today's range
3.1300 - 3.3900
ISIN
N/A
Source
NASDAQ
-
Autolus Therapeutics announces appointment of Martin Murphy as Non-executive Chairman
19 Apr 2021 07:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics to Participate in Investor Conferences Through April
01 Apr 2021 16:01:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Receives PRIME designation for AUTO1 for the treatment of adult ALL
01 Apr 2021 08:45:42 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Announces Updated Manufacturing Facility Strategy Leveraging its UK Operations
29 Mar 2021 08:00:00 By Nasdaq GlobeNewswire
-
04 Mar 2021 07:00:01 By Nasdaq GlobeNewswire
-
Autolus Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
24 Feb 2021 07:00:01 By Nasdaq GlobeNewswire
-
Autolus Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional ADSs
12 Feb 2021 16:01:00 By Nasdaq GlobeNewswire
-
Autolus Announces Pricing of Public Offering
09 Feb 2021 20:42:36 By Nasdaq GlobeNewswire
-
Autolus Announces Proposed Public Offering in the United States
08 Feb 2021 16:18:56 By Nasdaq GlobeNewswire
-
04 Feb 2021 07:00:01 By Nasdaq GlobeNewswire
-
Autolus Therapeutics provides business outlook for 2021 & 2022
06 Jan 2021 04:07:15 By Nasdaq GlobeNewswire
-
Autolus Therapeutics to participate in Investor Conferences through January
04 Jan 2021 07:00:00 By Nasdaq GlobeNewswire